Tikehau Capital SA's shares have taken a significant hit, dropping the most since its 2017 IPO, following the news that long-time backer Temasek has reduced its stake in the company at a discount. This move raises concerns among investors about the company's future and could signal a lack of confidence from one of its major supporters, making it a crucial moment for Tikehau as it navigates market reactions.

Tharimmune has successfully raised $545 million in a private placement, marking a significant milestone for the company as it seeks to advance its innovative therapies. This funding will not only bolster its research and development efforts but also comes alongside the appointment of a new CEO and president, signaling a fresh leadership direction. This is an exciting time for Tharimmune, as the new capital and leadership could enhance its position in the competitive biotech landscape.

Tailwind 2.0 has successfully priced its initial public offering at $150 million, with each unit set at $10. This marks a significant milestone for the company, showcasing investor confidence and the potential for growth in the market. The IPO is expected to provide Tailwind with the necessary capital to expand its operations and enhance its offerings, making it an exciting development for stakeholders and the industry.

BillionToOne has successfully raised $273.1 million in its upsized initial public offering (IPO), marking a significant milestone for the company. This influx of capital not only strengthens its financial position but also highlights investor confidence in its innovative approach to genetic testing. The successful IPO is crucial as it allows BillionToOne to expand its operations and invest in research and development, ultimately aiming to improve healthcare outcomes.

Functional Brands has successfully closed an $8 million private placement and completed its listing on Nasdaq, marking a significant milestone for the company. This funding will enable them to expand their operations and enhance their product offerings, which is crucial in a competitive market. The Nasdaq listing not only boosts their visibility but also provides greater access to capital, positioning them for future growth.

Grupo Aeromexico SAB and its shareholders have successfully raised around $300 million through an IPO and private placement, marking a significant return to public markets after being delisted three years ago. This move is crucial as it not only strengthens the airline's financial position but also signals renewed investor confidence in the aviation sector, which is vital for economic recovery.

Aeromexico has successfully raised $222.8 million in its long-awaited IPO in the US, backed by Apollo. This significant funding marks a pivotal moment for the airline as it aims to strengthen its financial position and expand its operations. The successful IPO not only reflects investor confidence in Aeromexico's recovery post-pandemic but also highlights the growing interest in the aviation sector as travel demand rebounds.

BillionToOne has successfully priced its upsized IPO at $60 per share, raising an impressive $273.1 million. This significant fundraising effort highlights the company's strong market position and investor confidence, paving the way for future growth and innovation in the biotech sector. The funds raised will likely be used to advance their cutting-edge technologies and expand their operations, making this a noteworthy event in the financial landscape.